ALB and Alzheimer disease: Preliminary results were first obtained by the identification of antibodies against Neu5Gc, native casein, and native egg albumin in the cerebrospinal fluid (CSF) of 13 healthy individuals, 17 AD patients with mild disease, 14 patients with intermediate, and 14 with severe AD.